News

National Statement for Emergency Use of Group O Red Blood Cells

The National Blood Authority {NBA) is pleased to advise that the National Statement for the Emergency Use of Group O Red Blood Cells (National Statement) is now available to view.

The National Statement underwent a jurisdictional and targeted public consultation process and has been endorsed by the professional colleges and organisations with representatives on the expert working group.

ANZSBT was very pleased to support the expert working group by providing two ANZSBT representatives to join the group and also to endorse the National Statement.

You can view the National Statement here…

ANZSBT Research Grant 2023

We are very pleased to advise that applications are now open for the ANZSBT Research Grant 2023. The purpose of the grant is to contribute towards basic science, clinical and translational research in transfusion or related fields in Australia and New Zealand.

In 2023, the Society will award a total sum of $75,000 comprising either a single grant of $75,000 or smaller grants totalling $75,000.

The Society invites applications from either individuals or groups in Australia and New Zealand who are involved in, or planning to undertake, research in transfusion or related fields.

An applicant needs to be an ANZSBT member.

You can find more information about membership and how to join on our website.  Application for membership alongside the grant application will be accepted.

For more information, please click on the link below and select the “ANZSBT Research Fund” tab.

https://members.anzsbt.org.au/awards-grants/awards-grants-general-information/

 

Canadian Blood Services Medical Director, Pathology Services

Location: Brampton, ON

The Medical Director, Laboratory Services (Medical Director) is responsible for the
medical leadership of the National Immunohematology Reference Laboratory where they
serve as the licensed Medical Director. The Medical Director is also responsible for the
medical leadership of the donor testing laboratories (blood group serologic testing) and
patient testing immunohematology laboratories, all of which may have licensed Medical
Directors. The Medical Director is also responsible for the appropriate staffing, leadership,
and the effective management of the physician staff, who are engaged primarily in
laboratory support, and will ensure adherence to organizational processes and objectives.
The position plays a major role in supporting excellence and innovation in laboratory
services at Canadian Blood Services to meet the needs of patients at the request of treating
physicians. As a member of the senior management team, the Medical Director works
closely with the Director, Testing and the Associate Director, Microbiology to lead and
influence the medical aspects of operational and reference laboratory services, as well as
the operational staff in the laboratories. Finally, the Medical Director is tasked with leading
and influencing policy and strategy discussions related to laboratory services at Canadian
Blood Services.

For more information, please click here.

 

HOW Collaborative Symposium

This may be of interest to members. This invitation has been been sent by the Haematology in Obstetrics and Women’s Health (HOW) Collaborative:

The Haematology in Obstetrics and Women’s Health (HOW) Collaborative is delighted to invite you to attend the next HOW Education Symposium on Friday 10 March at Leighton Hall, University of New South Wales, Sydney.

We have planned a comprehensive program for clinicians across a range of specialties and with a range of experiences. Please join us to be updated and to collaborate in future studies.

Topics include management of obstetric iron deficiency, viscoelastic testing in postpartum haemorrhage, venous thrombosis in transgender individuals, malignancy in pregnancy, and management of heavy menstrual bleeding. Our expert panel includes haematologists, anaesthetists, obstetricians/gynaecologists and maternal fetal medicine specialists.

You can find a detailed program and register for the meeting here: https://www.howcollaborative.org/meetings

The HOW Collaborative aims to achieve excellence in health outcomes in women with blood conditions related to pregnancy, birth, gynaecological and reproductive health in Australia and New Zealand. For those planning research relevant to the HOW Collaborative goals, there will be an opportunity to briefly present your study plans to the audience. This offers a unique opportunity for feedback from, and collaboration with, leading experts in the field. Please submit expressions of interest to info@howcollaborative.org by close of business on Monday 20 February.

Spaces are strictly limited, so don’t delay in registering. We look forward to seeing you at the meeting!

The HOW Collaborative

Immunoglobulin (Ig) Program Updates – December 2022 update now available

This may be of interest to Members.

The latest Ig Program Update is now available on the NBA website (http://www.blood.gov.au/Ig-program-updates).

 

Ig Program Updates provide a snapshot of the NBA’s current work program and priorities in the immunoglobulin space.

 

If you have any questions about the content of the updates, please contact the Ig Governance Team: iggovernance@blood.gov.au

BLOOD 2022 Published Abstracts in the Transfusion Medicine Journal

ANZSBT is excited to announce that the BLOOD 2022 abstracts are now published in the Transfusion Medicine Journal and can be viewed here.

Kill Or Cure Exhibition at the State Library of NSW

This may be of interest to members.

From the State Library of NSW:

We’re pleased to let you know about our free exhibition, Kill or Cure: A Taste of Medicine, which recently opened at the State Library of NSW. Not for the faint hearted, this exhibition takes visitors behind the curtain of Western medicine’s macabre history.
Visitors are encouraged to take a seat in the exhibition’s waiting area where ABC health reporter Tegan Taylor explains the four humours that once underpinned all medical thinking and were seen as essential for a balanced, healthy life. You’ll then be admitted into a hospital-like setting with 10 treatment rooms. Here, you’ll learn about the dubious, dangerous and often deadly techniques used to diagnose and treat the sick and diseased from 15th to the 19th centuries.

Members are asked if they would like to have a special curator-led tour of the exhibition.

Kill or Cure? is the State Library’s new exhibition that takes you behind the curtain of Western medicine’s macabre history.
Free entry until 22 Jan 2023.

25 Oct Minding your Mind with James O’Loghlin & Professor Ian Hickie
17 Nov Weird and wonderful treatments from medical history with Tegan Taylor, Dr Karl Kruszelnicki and Dr Naomi Koh Belie
22 Nov Life behind the mask: stories from healthcare workers with Dr Dinesh Palipana and Professor Mohamed Khadra

More info & bookings: sl.nsw.gov.au/whats-on

1 Shakespeare Place Sydney (02) 9273 1414 sl.nsw.gov.au/killorcure

Applications for the Prof Heimburger Award 2023 are now open

Applications for the Prof Heimburger Award 2023 are now open

CSL Behring is pleased to announce that applications for the 2023 cycle of the Prof Heimburger Award opened on 1 August 2022 and will close on 14 November 2022.

How to apply

Candidates should submit an application via the Prof Heimburger Award website. Applications can also be submitted via email to Heimburger.Award@cslbehring.com. Application forms should be submitted in English, along with a short CV and a one-page research proposal.

About the Prof Heimburger Award

The Prof Heimburger Award, created in honour of Professor Dr. Norbert Heimburger, supports early career researchers within the field of coagulation, thrombosis and acquired bleeding disorders. Each of the 5 winners of the award receives a global research grant, which has recently been increased to €25,000. The award is open to researchers who hold a medical degree or a PhD, and applicants with less than 5 years of faculty experience in the field will be preferred.

The award is now in its 16th year, with 75 winners so far. Some of the previous winners of the award include: Michiel Coppens (The Netherlands), Mindy Simpson (USA) and Carolyn Millar (UK).  Six Australians have received the award, including one in the 2022 cycle.

 

RACP 2023 CPD framework– Important information for physicians

This RACP communication may be of interest to members.

The 2023 changes to CPD requirements have come from the Medical Board of Australia and Medical Council of New Zealand (MCNZ) | Te Kaunihera Rata o Aotearoa.

Professor Martin Veysey, Chair of the College CPD Committee, explains the CPD activities physicians will need to complete from 1 January 2023 in this video.

You can read more about the new requirements on our website and find helpful CPD resources and templates in the MyCPD Interactive Handbook.

 For more information about these changes and to answer any questions you might have, register for our 2023 MyCPD Framework Q&A webinar on Tuesday, 22 November 2022 from 5pm to 6pm AEDT / 7pm to 8pm NZDT.

We will discuss the upcoming changes, what they mean for you, and help you identify meaningful professional development activities.

Contact MyCPD@racp.edu.au or MyCPD@racp.org.nz for any assistance or if you would like to contribute to the continuous development of supporting resources.